Neopeutics

Neopeutics is a private, pre-clinical contract research partner founded in 2016 and based in Cambridge, USA. It operates a services-based business model, providing clients with a cost-effective technology platform for drug discovery that integrates proprietary HTS and bioinformatics tools to reduce downstream attrition rates. The company is pre-revenue, targeting specialized therapeutic discovery, particularly in natural products and nutraceuticals, and has been recognized with a Frost & Sullivan award for its innovative approach. Its operations involve clarifying its non-involvement with certain third-party product claims, as noted in a public disclaimer.

Proprietary integrated platform combining quantitative high-throughput screening (HTS) technology with customizable bioinformatics software tools for drug discovery, aimed at reducing downstream attrition rates.

Operates in the crowded contract research organization (CRO) and research tools market, competing against large global players and many niche specialists. Differentiates by focusing on cost-effective, integrated technology for small-scale programs and specializing in natural product discovery, a complex area where broad CROs may have less depth.